Context Therapeutics Inc.

CNTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.47

$0.00 (+0.99%)

Nov 2, 2026, 10:10 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $42.76M

Enterprise Value $15.19K

Beta 1.75

Average Volume 2.32M

Shares Outstanding (Diluted) 95.18M

Shares Change YoY 0%

Institutional Ownership 77.93%

Exchange NASDAQ

ISIN US21077P1084

Price Performance

Price Change 1M -23.7%

Price Change 3M -82.3%

Price Change 6M -80.8%

Price Change YTD -70.0%

Price Change 1Y -46.7%

Price Change 3Y -53.5%

Price Change 5Y -93.3%

1M CAGR (ann.) -23.4%

1Y CAGR (ann.) -44.7%

5Y CAGR (ann.) N/A

All-Time CAGR -38.1%

Valuation

PE Ratio -0.98

Forward PE N/A

PEG Ratio 0.04

Forward PEG N/A

PS Ratio N/A

Forward PS N/A

PB Ratio 1.12

P/FCF Ratio -1.26

P/Adj. FCF Ratio -1.20

P/OCF Ratio -1.31

EV/Sales N/A

EV/EBIT -0.00

EV/EBITDA -0.00

EV/FCF -0.00

Earnings Yield -102.1%

FCF Yield -79.6%

Adj. FCF Yield -83.3%

Financial Health

Net Cash $42.75M

Total Debt $244.99K

Cash & Short-Term Investments $42.99M

Total Assets $46.13M

Current Ratio 5.81

Quick Ratio 5.81

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -138.66

Interest Coverage 0.00

Altman Z-Score -3.52

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -4.7%

Returns

Return on Assets -99.6%

Return on Equity -82.1%

Return on Invested Capital -126.8%

Return on Capital Employed -127.4%

Return on Tangible Assets -99.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 19.7%

EPS CAGR 5Y -96.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -29.2%

FCF CAGR 5Y -490.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y -2.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.10

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5.25

Price Target Upside 1017.0%

Cash Flow

Operating Cash Flow $-33.97M

Free Cash Flow $-34.03M

Adj. Free Cash Flow $-35.61M

FCF Per Share -$0.36

OCF Per Share -$0.36

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-4.07K

Operating Income $-48.73M

EBITDA $-45.91M

Net Income $-45.96M

EPS (Diluted) -$0.48

Revenue / Employee N/A

Profit / Employee $-3.06M

Employees 15